======= LARGE ======= == Gene Information == * **Official Symbol**: LARGE1 * **Official Name**: LARGE xylosyl- and glucuronyltransferase 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9215|9215]] * **UniProt**: [[https://www.uniprot.org/uniprot/O95461|O95461]] * **Interactions**: [[https://thebiogrid.org/search.php?search=LARGE&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20LARGE|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603590|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene, which is one of the largest in the human genome, encodes a member of the N-acetylglucosaminyltransferase gene family. It encodes a glycosyltransferase which participates in glycosylation of alpha-dystroglycan, and may carry out the synthesis of glycoprotein and glycosphingolipid sugar chains. It may also be involved in the addition of a repeated disaccharide unit. Mutations in this gene cause MDC1D, a novel form of congenital muscular dystrophy with severe cognitive disability and abnormal glycosylation of alpha-dystroglycan. Alternative splicing of this gene results in two transcript variants that encode the same protein. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: N/A |Glyco transf 8| |xylosyltransferase activity| |UDP-xylosyltransferase activity| |N-acetylglucosamine metabolic process| |transferase activity, transferring glycosyl groups| |protein O-linked mannosylation| |muscle cell cellular homeostasis| |acetylglucosaminyltransferase activity| |glycosphingolipid biosynthetic process| |glucosamine-containing compound metabolic process| |protein mannosylation| |glucuronosyltransferase activity| |skeletal muscle tissue regeneration| |mannosylation| |amino sugar metabolic process| |manganese ion binding| |integral component of Golgi membrane| |tissue regeneration| |glycolipid biosynthetic process| |glycosphingolipid metabolic process| |sphingolipid biosynthetic process| |glycolipid metabolic process| |liposaccharide metabolic process| |protein O-linked glycosylation| |membrane lipid biosynthetic process| |skeletal muscle organ development| |sphingolipid metabolic process| |regeneration| |membrane lipid metabolic process| |protein glycosylation| |macromolecule glycosylation| |glycosylation| |muscle organ development| |glycoprotein biosynthetic process| |anatomical structure homeostasis| |glycoprotein metabolic process| |developmental growth| |growth| |muscle structure development| |wound healing| |response to wounding| |lipid biosynthetic process| |carbohydrate derivative biosynthetic process| |Golgi membrane| |cellular homeostasis| |cellular lipid metabolic process| |Golgi apparatus| |carbohydrate derivative metabolic process| |lipid metabolic process| |organonitrogen compound biosynthetic process| |homeostatic process| |cellular macromolecule biosynthetic process| |tissue development| |macromolecule biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp518|RK-33 8μM R08 exp518]]|-1.7| |[[:results:exp176|Apcin 50 to 100μM on day4 R04 exp176]]|1.74| |[[:results:exp318|ABT-702 5μM R07 exp318]]|1.89| |[[:results:exp445|∆-9-Tetrahydrocannabinol 30μM R08 exp445]]|2.1| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12019 * **Expression level (log2 read counts)**: 4.17 {{:chemogenomics:nalm6 dist.png?nolink |}}